RecruitingNCT07010250
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
146 participants
Start Date
Nov 3, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with anca-associated vasculitis, diabetic nephropathies, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07010250
Related Trials
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
NCT030019471 location
Correlation of Microbiome and Metabonomics With IgA Nephropathy
NCT051908485 locations
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
NCT075412879 locations
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
NCT07251179
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
NCT048587241 location